FDA exemption of Class I, Tier I devices
This article was originally published in The Gray Sheet
Several firms submit comments on the recently published FDA proposal to exempt 164 devices from 510(k) review. Urging that unscented menstrual pads be added to the group of exempted devices, Nancy Buc, lawyer for the Washington, D.C. firm Buc, Levitt & Beardsley, says that "if ever a product warranted an exemption, this is it." Coltene/Whaledent opposes the proposed exemption of retentive and splinting pins and root canal posts. Eliminating premarket notification requirements, the firm argues, would "result in substandard products being made available" that would become "part of permanent dental restorations, wreaking havoc on the...American public." The firm says that it manufactures a number of dental pins and posts that are preamendment devices as well as an active post under 510(k) clearance
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.